Literature DB >> 21873105

Factors predicting survival after diagnosis of laryngeal cancer.

Heribert Ramroth1, Anja Schoeps, Elisabeth Rudolph, Gerhard Dyckhoff, Peter Plinkert, Burkhard Lippert, Klaus Feist, Klaus-Wolfgang Delank, Klaus Scheuermann, Gerald Baier, Ingo Ott, Sami Chenouda, Heiko Becher, Andreas Dietz.   

Abstract

Survival in patients with laryngeal cancer has not increased remarkably within the last years. It is presumed that a variety of factors act jointly in predicting survival after diagnosis: tumour stage, tumour site, treatment approaches, age and comorbidities. The aim of this German clinical multi-centre study is to present results from multivariate analysis. A retrospective cohort study was conducted in four hospitals in South-West Germany. Incident cases with laryngeal squamous cell carcinoma were included for the years 1998 to 2004, resulting in a population sample of 594 patients. Multivariate regression analysis was performed using the Cox proportional hazards model. Patients were followed up for 64.1months on average. Overall 5-year survival was 66% (95% confidence interval (CI): 62-70%). The strongest risk factors in multivariate analysis were age at first diagnosis (hazard ratio (HR): 1.5; 95% CI: 1.5-1.7 per each additional 10years), tumour stage, and the development of recurrences (HR 3.1; 95% CI: 2.3-4.2) or second primary carcinomas (HR 2.1; 95% CI: 1.4-3.1). A somewhat weaker effect was shown for patients with comorbidities (using Charlson's comorbidity index). The choice of treatment did not strongly affect survival when adjusting for other factors, possibly because the optimal treatment approach was applied for the specific constitution and requirements of each patient. For future research it would be desirable to study the effect of treatment on quality of life in multivariate analysis as well as other modifiable risk factors as smoking and drinking reduction or cessation after diagnosis.
Copyright © 2011 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 21873105     DOI: 10.1016/j.oraloncology.2011.08.003

Source DB:  PubMed          Journal:  Oral Oncol        ISSN: 1368-8375            Impact factor:   5.337


  16 in total

1.  miR-21 and miR-375 microRNAs as candidate diagnostic biomarkers in squamous cell carcinoma of the larynx: association with patient survival.

Authors:  An Hu; Jing-Juan Huang; Wei-Hua Xu; Xiao-Jie Jin; Ji-Ping Li; Yuan-Jia Tang; Xin-Fang Huang; Hui-Juan Cui; Guang-Bin Sun
Journal:  Am J Transl Res       Date:  2014-10-11       Impact factor: 4.060

2.  MiR-21/miR-375 ratio is an independent prognostic factor in patients with laryngeal squamous cell carcinoma.

Authors:  An Hu; Jing-Juan Huang; Wei-Hua Xu; Xiao-Jie Jin; Ji-Ping Li; Yuan-Jia Tang; Xin-Fang Huang; Hui-Juan Cui; Guang-Bin Sun; Rui-Lin Li; Jun-Li Duan
Journal:  Am J Cancer Res       Date:  2015-04-15       Impact factor: 6.166

3.  Curcumin suppresses invasiveness and vasculogenic mimicry of squamous cell carcinoma of the larynx through the inhibition of JAK-2/STAT-3 signaling pathway.

Authors:  An Hu; Jing-Juan Huang; Xiao-Jie Jin; Ji-Ping Li; Yuan-Jia Tang; Xin-Fang Huang; Hui-Juan Cui; Wei-Hua Xu; Guang-Bin Sun
Journal:  Am J Cancer Res       Date:  2014-12-15       Impact factor: 6.166

4.  Microbiota in the Throat and Risk Factors for Laryngeal Carcinoma.

Authors:  Hongli Gong; Yi Shi; Xia Zhou; Chunping Wu; Pengyu Cao; Chen Xu; Dongsheng Hou; Yuezhu Wang; Liang Zhou
Journal:  Appl Environ Microbiol       Date:  2014-09-19       Impact factor: 4.792

5.  Expression of Podoplanin in Laryngeal Squamous Cell Carcinoma and Dysplasia.

Authors:  Badawia Bayoumy Ibrahim; Mostafa Mohamed Salem; Rasha Ahmed Khairy; Reema Abdul Rahman Al Gunaid
Journal:  J Clin Diagn Res       Date:  2017-05-01

6.  Prognostic value of interleukin-6 and interleukin-8 in laryngeal squamous cell cancer.

Authors:  Wenwei Hao; Yongping Zhu; Huifang Zhou
Journal:  Med Oncol       Date:  2012-12-27       Impact factor: 3.064

7.  Hypoxia-Inducible Factor-1α Expression in Indonesian Laryngeal Squamous Cell Carcinoma Patients.

Authors:  Agus Surono; Priyanto Priyanto; Sagung Rai Indrasari
Journal:  J Oncol       Date:  2016-11-01       Impact factor: 4.375

8.  Retrospective analysis of prognostic factors in 205 patients with laryngeal squamous cell carcinoma who underwent surgical treatment.

Authors:  Si-Yi Zhang; Zhong-Ming Lu; Xiao-Ning Luo; Liang-Si Chen; Ping-Jiang Ge; Xin-Han Song; Shao-Hua Chen; Yi-Long Wu
Journal:  PLoS One       Date:  2013-04-04       Impact factor: 3.240

9.  miR-144-3p, a tumor suppressive microRNA targeting ETS-1 in laryngeal squamous cell carcinoma.

Authors:  Si-Yi Zhang; Zhong-Ming Lu; Ye-Feng Lin; Liang-Si Chen; Xiao-Ning Luo; Xin-Han Song; Shao-Hua Chen; Yi-Long Wu
Journal:  Oncotarget       Date:  2016-03-08

10.  A Novel Inflammation- and Nutrition-Based Prognostic System for Patients with Laryngeal Squamous Cell Carcinoma: Combination of Red Blood Cell Distribution Width and Body Mass Index (COR-BMI).

Authors:  Yan Fu; Yize Mao; Shiqi Chen; Ankui Yang; Quan Zhang
Journal:  PLoS One       Date:  2016-09-22       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.